Zobrazeno 1 - 4
of 4
pro vyhledávání: '"L Soriano Gutierrez"'
Autor:
P Miralles-Albors, S Fernández-Molina, M Gómez-Valent, L Soriano-Gutierrez, G Puig Comas, V de Pedro Ambrosio, A Perez Contel
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Palbociclib is a cyclin-dependent kinases 4/6 inhibitor, indicated in metastatic or locally advanced breast cancer, hormone receptor-positive and HER2-negative. The treatment is performed until unacceptable toxicity or progression of the d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Cruel Niebla, P Miralles, V de Pedro Ambrosio, A Perez Contel, L Soriano Gutierrez, G Molas Ferrer
Publikováno v:
Eur J Hosp Pharm
Background Axitinib is a potent and selective tyrosine kinase inhibitor of vascular endothelial growth factor receptors (VEGFR)−1, VEGFR-2 and VEGFR-3. These receptors are implicated in pathologic angiogenesis, tumour growth and metastatic progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd9a5cd74e18d526750596413fc47435
https://europepmc.org/articles/PMC7535475/
https://europepmc.org/articles/PMC7535475/
Autor:
R. Garriga Biosca, L Soriano Gutierrez, E Clot Silla, S. Redondo Capafons, R. Pla Poblador, P March López
Publikováno v:
European Journal of Hospital Pharmacy. 21:A109.2-A110
Background The prevalence of off-label use is not well established. The indications for such uses have not been collected, neither has the literature that supports them. Purpose To establish the prevalence of off-label use of certain chemotherapy dru